Risk of invasive fungal infections among patients treated with disease modifying treatments for multiple sclerosis: a comprehensive review-Reference-Cited by-同舟云学术

Risk of invasive fungal infections among patients treated with disease modifying treatments for multiple sclerosis: a comprehensive review

Published:2021-04-21 Issue:8 Volume:20 Page:925-936
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Scotto R.¹,Reia A.²,Buonomo A.R.¹,Moccia M.²,Viceconte G.¹,Pisano E.²,Zappulo E.¹,Brescia Morra V.²,Gentile I.¹

Affiliation:

1. Department of Clinical Medicine and Surgery, Section of Infectious Diseases, University of Naples Federico II, Naples, Italy

2. Department of Neuroscience, Reproductive Science and Odontostomatology, Multiple Sclerosis Clinical Care and Research Centre, University of Naples Federico II, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2021.1918673

Reference99 articles.

1. Candida infections in psoriatic patients on anti-IL17 therapy: a case series

2. Disseminated Histoplasmosis and Pneumocystis Pneumonia in a Child With Crohn Disease Receiving Infliximab

3. Early cryptococcal meningitis following treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia

4. Monoclonal Antibodies for Relapsing Multiple Sclerosis: A Review of Recently Marketed and Late-Stage Agents

5. Monoclonal Antibodies and Recombinant Immunoglobulins for the Treatment of Multiple Sclerosis

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fungemia by Wickerhamomyces anomalus—A Narrative Review;Pathogens;2024-03-21

2. Musculoskeletal and CNS coccidiomycosis in an individual with multiple sclerosis on fingolimod – A case report;IDCases;2024

3. Automated Blood Cell Counting in Candidaemia: A Comparative Study of Sysmex-X Series 500 and KX-21 Counters;Infection Epidemiology and Microbiology;2023-12-01

4. Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi method;Therapeutic Advances in Neurological Disorders;2023-01

5. In vivo degradation forms, anti-degradation strategies, and clinical applications of therapeutic peptides in non-infectious chronic diseases;European Journal of Pharmacology;2022-10